Female Health Company to bring PE solution to intimacy health aisle

MIAMI — The Female Health Company/Veru Healthcare on Friday announced the U.S. launch of PreBoost (topical 4% benzocaine wipes) that helps in the prevention of premature ejaculation. PreBoost is a new, proprietary over-the-counter male genital desensitizer that helps in temporarily prolonging the time until ejaculation in men with premature ejaculation.



“Premature ejaculation is a large and underserved market,” commented Mitchell Steiner, president and CEO of The Female Health Company/Veru Healthcare. “We are using targeted digital, social media marketing and online optimization capabilities to drive traffic to the PreBoost e-commerce site," he said. "The next phase of launch will be to include a sampling program targeting urologists, engaging a marketing partner to co-promote PreBoost, introducing the product to large chain pharmacies and other OTC distribution outlets, and seeking out licensing opportunities for markets outside the U.S.”



“I invented PreBoost to help the millions of men who suffer from PE and for those couples that want to extend their sexual pleasure,” stated Harry Fisch, the company’s COO. “We believe PreBoost has significant advantages over currently available therapies, especially with regard to ease of use, delivery system and convenience.”



Unlike currently available OTC desensitizing sprays or gels that contain lidocaine or benzocaine, PreBoost is an individually packaged wipe containing 4% benzocaine, which allows for discrete, direct and precise application of the correct dosage each time. It is applied topically and dries quickly which prevents the potential for transference to a partner.



The product is now available and can be purchased through the e-commerce site http://preboost.com.